Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment

This case report follows a 10-year-old castrated male Miniature Schnauzer dog presented with a history of incomplete surgical resection of an oral malignant melanoma (amelanotic type) on the right mandible. Melanoma vaccine therapy was administered due to incomplete surgical resection, however, new...

Full description

Bibliographic Details
Main Authors: KR Kim, DH Kim, MJ Jung, DM Sihn, SW Jeong, JH Kim
Format: Article
Language:English
Published: Czech Academy of Agricultural Sciences 2023-12-01
Series:Veterinární Medicína
Subjects:
Online Access:https://vetmed.agriculturejournals.cz/artkey/vet-202312-0004_canine-oral-melanoma-with-suspected-pulmonary-metastasis-combination-of-immunotherapy-and-tyrosine-kinase-inhi.php
_version_ 1797371026148950016
author KR Kim
DH Kim
MJ Jung
DM Sihn
SW Jeong
JH Kim
author_facet KR Kim
DH Kim
MJ Jung
DM Sihn
SW Jeong
JH Kim
author_sort KR Kim
collection DOAJ
description This case report follows a 10-year-old castrated male Miniature Schnauzer dog presented with a history of incomplete surgical resection of an oral malignant melanoma (amelanotic type) on the right mandible. Melanoma vaccine therapy was administered due to incomplete surgical resection, however, new masses were detected on the contralateral mandible and suspected pulmonary metastasis occurred at 2 weeks and 7 months, respectively, following the first melanoma vaccination. At the time of detecting the pulmonary metastasis, targeted chemotherapy was initiated with the owner's consent using imatinib (10 mg/kg/day, p.o.), a tyrosine kinase inhibitor (TKI). The patient did not show any significant adverse events related to both anticancer treatments. Three months following the first dose of imatinib, the absence of the suspected pulmonary metastatic nodules on radiography indicated complete remission. In conclusion, this report describes the achievement of clinical remission of suspected pulmonary metastatic oral malignant melanoma and an extension of survival time in a dog given a combination treatment of immunotherapy and tyrosine kinase inhibitor.
first_indexed 2024-03-08T18:13:56Z
format Article
id doaj.art-a10f0a4f47b14430aa683b2c92e131be
institution Directory Open Access Journal
issn 0375-8427
1805-9392
language English
last_indexed 2024-03-08T18:13:56Z
publishDate 2023-12-01
publisher Czech Academy of Agricultural Sciences
record_format Article
series Veterinární Medicína
spelling doaj.art-a10f0a4f47b14430aa683b2c92e131be2023-12-31T18:43:23ZengCzech Academy of Agricultural SciencesVeterinární Medicína0375-84271805-93922023-12-01681247748210.17221/90/2023-VETMEDvet-202312-0004Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatmentKR Kim0DH Kim1MJ Jung2DM Sihn3SW Jeong4JH Kim5KU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaKU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaKU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaKU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaKU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaKU Animal Cancer Center, Konkuk University Veterinary Medical Teaching Hospital, Seoul, Republic of KoreaThis case report follows a 10-year-old castrated male Miniature Schnauzer dog presented with a history of incomplete surgical resection of an oral malignant melanoma (amelanotic type) on the right mandible. Melanoma vaccine therapy was administered due to incomplete surgical resection, however, new masses were detected on the contralateral mandible and suspected pulmonary metastasis occurred at 2 weeks and 7 months, respectively, following the first melanoma vaccination. At the time of detecting the pulmonary metastasis, targeted chemotherapy was initiated with the owner's consent using imatinib (10 mg/kg/day, p.o.), a tyrosine kinase inhibitor (TKI). The patient did not show any significant adverse events related to both anticancer treatments. Three months following the first dose of imatinib, the absence of the suspected pulmonary metastatic nodules on radiography indicated complete remission. In conclusion, this report describes the achievement of clinical remission of suspected pulmonary metastatic oral malignant melanoma and an extension of survival time in a dog given a combination treatment of immunotherapy and tyrosine kinase inhibitor.https://vetmed.agriculturejournals.cz/artkey/vet-202312-0004_canine-oral-melanoma-with-suspected-pulmonary-metastasis-combination-of-immunotherapy-and-tyrosine-kinase-inhi.phpdogimatinibmalignant melanoma
spellingShingle KR Kim
DH Kim
MJ Jung
DM Sihn
SW Jeong
JH Kim
Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
Veterinární Medicína
dog
imatinib
malignant melanoma
title Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
title_full Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
title_fullStr Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
title_full_unstemmed Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
title_short Canine oral melanoma with suspected pulmonary metastasis: Combination of immunotherapy and tyrosine kinase inhibitor treatment
title_sort canine oral melanoma with suspected pulmonary metastasis combination of immunotherapy and tyrosine kinase inhibitor treatment
topic dog
imatinib
malignant melanoma
url https://vetmed.agriculturejournals.cz/artkey/vet-202312-0004_canine-oral-melanoma-with-suspected-pulmonary-metastasis-combination-of-immunotherapy-and-tyrosine-kinase-inhi.php
work_keys_str_mv AT krkim canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment
AT dhkim canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment
AT mjjung canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment
AT dmsihn canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment
AT swjeong canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment
AT jhkim canineoralmelanomawithsuspectedpulmonarymetastasiscombinationofimmunotherapyandtyrosinekinaseinhibitortreatment